Antitumor effect of combination of hyperthermotherapy and 5-aminolevulinic acid (ALA).

Anticancer research (2013-06-20)
Kiwamu Takahashi, Takeo Hasegawa, Takuya Ishii, Atsuko Suzuki, Motowo Nakajima, Kazuko Uno, Iuko Yasuda, Atsuko Kishi, Kaori Sadamoto, Fuminori Abe, Tohru Tanaka
RESUMO

5-Aminolevulinic acid (ALA) is a precursor of heme. ALA is used as a photosensitive substance in photodynamic diagnosis (PDD) and photodynamic therapy (PDT) because heme metabolism is abnormal in tumor cells and a photosensitive metabolite of heme synthesis from ALA, protoporphyrin IX (PpIX), specifically accumulates in tumors. We investigated the enhancement of the antitumor effect by combination of ALA and hyperthermotherapy (HT) using a transplanted tumor model with Lewis lung carcinoma cells (3LL) in mice. Animals were divided into four test groups: control (untreated), HT, and HT plus ALA (100 or 300 mg/kg) groups, and HT by bathing at 43°C for 20 min was performed at five days after transplantation. ALA was administered once at the above doses three hours before HT by intraperitoneal injection. The tumor sizes at five days after HT were 5.2- and 2.6-times greater than those at the time of HT in the control and HT groups, respectively. In contrast, PpIX accumulation in the tumor region was noted three hours after ALA administration, the HT+ALA group given at 100 or 300 mg/kg of ALA inhibited tumor growth to 1.3- and 1.1-times increases in the tumor size. Therefore, ALA administration markedly enhanced the tumor growth-inhibitory effect of HT.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Protoporphyrin IX disodium salt, ≥90% (HPLC)